Amgen Total Assets 2006-2019 | AMGN

Amgen total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Amgen total assets for the quarter ending December 31, 2019 were $59.707B, a 10.1% decline year-over-year.
  • Amgen total assets for 2019 were $59.707B, a 10.1% decline from 2018.
  • Amgen total assets for 2018 were $66.416B, a 16.93% decline from 2017.
  • Amgen total assets for 2017 were $79.954B, a 3% increase from 2016.
Amgen Annual Total Assets
(Millions of US $)
2019 $59,707
2018 $66,416
2017 $79,954
2016 $77,626
2015 $71,449
2014 $69,009
2013 $66,125
2012 $54,298
2011 $48,871
2010 $43,486
2009 $39,629
2008 $36,427
2007 $34,639
2006 $33,788
2005 $29,297
Amgen Quarterly Total Assets
(Millions of US $)
2019-12-31 $59,707
2019-09-30 $59,535
2019-06-30 $59,373
2019-03-31 $63,997
2018-12-31 $66,416
2018-09-30 $67,333
2018-06-30 $67,684
2018-03-31 $71,164
2017-12-31 $79,954
2017-09-30 $80,331
2017-06-30 $79,587
2017-03-31 $77,862
2016-12-31 $77,626
2016-09-30 $78,150
2016-06-30 $75,471
2016-03-31 $75,116
2015-12-31 $71,449
2015-09-30 $71,869
2015-06-30 $71,209
2015-03-31 $68,952
2014-12-31 $69,009
2014-09-30 $70,775
2014-06-30 $69,534
2014-03-31 $67,004
2013-12-31 $66,125
2013-09-30 $57,073
2013-06-30 $52,610
2013-03-31 $51,640
2012-12-31 $54,298
2012-09-30 $55,448
2012-06-30 $52,226
2012-03-31 $49,250
2011-12-31 $48,871
2011-09-30 $45,765
2011-06-30 $46,936
2011-03-31 $42,714
2010-12-31 $43,486
2010-09-30 $43,534
2010-06-30 $40,800
2010-03-31 $40,366
2009-12-31 $39,629
2009-09-30 $40,940
2009-06-30 $38,840
2009-03-31 $37,380
2008-12-31 $36,427
2008-09-30 $36,998
2008-06-30 $36,061
2008-03-31 $36,128
2007-12-31 $34,639
2007-09-30 $33,452
2007-06-30 $32,971
2007-03-31 $32,570
2006-12-31 $33,788
2006-09-30 $32,586
2006-06-30 $31,288
2006-03-31 $31,315
2005-12-31 $29,297
2005-09-30 $29,132
2005-06-30 $28,038
2005-03-31 $27,420
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $116.941B $23.362B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $91.719B 11.86
CSL (CSLLY) Australia $79.295B 0.00
Vertex Pharmaceuticals (VRTX) United States $56.324B 51.12
Biogen (BIIB) United States $51.654B 8.82
Regeneron Pharmaceuticals (REGN) United States $49.455B 20.95
Illumina (ILMN) United States $39.550B 40.89
Seattle Genetics (SGEN) United States $18.823B 0.00
Alexion Pharmaceuticals (ALXN) United States $18.600B 8.65
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $14.949B 32.07
BioMarin Pharmaceutical (BMRN) United States $14.306B 611.61
Genmab (GNMSF) Denmark $12.862B 41.37
BioNTech SE (BNTX) Germany $12.444B 0.00
Alnylam Pharmaceuticals (ALNY) United States $11.782B 0.00
Galapagos (GLPG) Belgium $11.779B 25.73
Bio-Rad Laboratories (BIO.B) United States $9.935B 46.43
Moderna (MRNA) United States $9.887B 0.00
QIAGEN (QGEN) Netherlands $9.213B 28.09
Exact Sciences (EXAS) United States $8.567B 0.00
BeiGene (BGNE) Cayman Islands $8.176B 0.00
Sarepta Therapeutics (SRPT) United States $7.345B 0.00
Bio-Techne Corp (TECH) United States $7.072B 48.40
Guardant Health (GH) United States $6.398B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.032B 0.00
Ascendis Pharma (ASND) Denmark $5.414B 0.00
Exelixis (EXEL) United States $5.262B 16.89
Horizon Therapeutics Public (HZNP) Ireland $5.235B 13.83
Reata Pharmaceuticals (RETA) United States $4.984B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.980B 0.00
Repligen (RGEN) United States $4.820B 88.14
Amarin (AMRN) Ireland $4.730B 0.00
Acceleron Pharma (XLRN) United States $4.643B 0.00
China Biologic Products (CBPO) China $4.279B 25.40
Vir Biotechnology (VIR) United States $3.762B 0.00
MorphoSys AG (MOR) Germany $3.364B 0.00
Mirati Therapeutics (MRTX) United States $3.318B 0.00
Adaptive Biotechnologies (ADPT) United States $3.206B 0.00
Blueprint Medicines (BPMC) United States $3.140B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.130B 0.00
Global Blood Therapeutics (GBT) United States $3.110B 0.00
Zai Lab (ZLAB) China $2.961B 0.00
Immunomedics (IMMU) United States $2.747B 0.00
NeoGenomics (NEO) United States $2.695B 116.86
Emergent Biosolutions (EBS) United States $2.663B 18.49
Bluebird Bio (BLUE) United States $2.657B 0.00
Genmab (GMAB) Denmark $2.588B 10.15
CRISPR Therapeutics AG (CRSP) Switzerland $2.545B 43.11
MyoKardia (MYOK) United States $2.488B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.452B 0.00
Halozyme Therapeutics (HALO) United States $2.416B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.329B 0.00
Amicus Therapeutics (FOLD) United States $2.300B 0.00
Alkermes (ALKS) Ireland $2.272B 180.00
Arena Pharmaceuticals (ARNA) United States $2.238B 5.83
RA PHARMCTL INC (RARX) United States $2.220B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.138B 0.00
Denali Therapeutics (DNLI) United States $1.995B 0.00
UniQure (QURE) Netherlands $1.959B 0.00
Epizyme (EPZM) United States $1.792B 0.00
Alector (ALEC) United States $1.787B 0.00
Viela Bio (VIE) United States $1.769B 0.00
Fate Therapeutics (FATE) United States $1.684B 0.00
Principia Biopharma (PRNB) United States $1.673B 0.00
Eidos Therapeutics (EIDX) United States $1.618B 0.00
Insmed (INSM) United States $1.541B 0.00
Arvinas (ARVN) United States $1.538B 0.00
Zymeworks (ZYME) Canada $1.470B 0.00
Akcea Therapeutics (AKCA) United States $1.345B 28.93
Dicerna Pharmaceuticals (DRNA) United States $1.263B 0.00
REGENXBIO (RGNX) United States $1.258B 0.00
Inovio Pharmaceuticals (INO) United States $1.213B 0.00
Coherus BioSciences (CHRS) United States $1.148B 13.66
Ligand Pharmaceuticals (LGND) United States $1.102B 34.25
Editas Medicine (EDIT) United States $1.095B 0.00
Twist Bioscience (TWST) United States $1.063B 0.00
Zealand Pharma (ZEAL) Denmark $1.054B 0.00
Myriad Genetics (MYGN) United States $1.048B 18.50
NextCure (NXTC) United States $1.007B 0.00
PHARMA MAR SA (PHMMF) Spain $0.983B 0.00
Adverum Biotechnologies (ADVM) United States $0.911B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
NGM Biopharmaceuticals (NGM) United States $0.886B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.877B 0.00
Sangamo Therapeutics (SGMO) United States $0.737B 0.00
Cytokineticsorporated (CYTK) United States $0.699B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.680B 0.00
Novavax (NVAX) United States $0.672B 0.00
Kadmon Holdings (KDMN) United States $0.637B 0.00
Athenex (ATNX) United States $0.615B 0.00
Pharming Group (PHGUF) Netherlands $0.613B 0.00
Frequency Therapeutics (FREQ) United States $0.609B 0.00
Codexis (CDXS) United States $0.607B 0.00
Retrophin (RTRX) United States $0.594B 0.00
Cara Therapeutics (CARA) United States $0.589B 0.00
Intellia Therapeutics (NTLA) United States $0.583B 0.00
Arcus Biosciences (RCUS) United States $0.582B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.582B 0.00
Bellus Health (BLU) Canada $0.554B 0.00
GENFIT S.A (GNFT) France $0.552B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.537B 0.00
Intrexon (PGEN) United States $0.533B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.528B 0.00
Clovis Oncology (CLVS) United States $0.524B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.491B 4.32
Compugen (CGEN) Israel $0.491B 0.00
Castle Biosciences (CSTL) United States $0.486B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
ANI Pharmaceuticals (ANIP) United States $0.457B 8.24
Mesoblast (MESO) Australia $0.435B 0.00
DBV Technologies S.A (DBVT) France $0.434B 0.00
MeiraGTx Holdings (MGTX) United States $0.429B 0.00
AC Immune SA (ACIU) Switzerland $0.429B 9.92
Morphic Holding (MORF) United States $0.427B 0.00
Vericel (VCEL) United States $0.422B 62.60
Heska (HSKA) United States $0.419B 0.00
Anika Therapeutics (ANIK) United States $0.415B 14.29
Aquinox Pharmaceuticals (NLTX) United States $0.405B 0.00
MiMedx (MDXG) United States $0.403B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
Scholar Rock Holding (SRRK) United States $0.400B 0.00
Verastem (VSTM) United States $0.400B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.385B 0.00
Prothena (PRTA) Ireland $0.383B 0.00
AnaptysBio (ANAB) United States $0.382B 0.00
Agenus (AGEN) United States $0.380B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.371B 0.00
UROGEN PHARMA (URGN) United States $0.370B 0.00
Cellectis S.A (CLLS) France $0.365B 0.00
Merus (MRUS) Netherlands $0.360B 0.00
Cue Biopharma (CUE) United States $0.352B 0.00
BioDelivery Sciences (BDSI) United States $0.340B 39.22
Puma Biotechnology (PBYI) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.336B 10.07
Sorrento Therapeutics (SRNE) United States $0.328B 0.00
Athersys (ATHX) United States $0.322B 0.00
WAVE Life Sciences (WVE) Singapore $0.319B 0.00
Precision BioSciences (DTIL) United States $0.318B 0.00
NantKwest (NK) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.297B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
CytomX Therapeutics (CTMX) United States $0.289B 0.00
Mersana Therapeutics (MRSN) United States $0.287B 0.00
Kala Pharmaceuticals (KALA) United States $0.285B 0.00
ADMA Biologics Inc (ADMA) United States $0.265B 0.00
Avid Bioservices (CDMO) United States $0.264B 0.00
Albireo Pharma (ALBO) United States $0.248B 0.00
Kamada (KMDA) Israel $0.244B 10.17
Seres Therapeutics (MCRB) United States $0.244B 0.00
Alcobra (ARCT) United States $0.239B 0.00
Sutro Biopharma (STRO) United States $0.226B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.226B 0.00
MannKind (MNKD) United States $0.225B 0.00
Stemline Therapeutics (STML) United States $0.222B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.218B 0.00
Syros Pharmaceuticals (SYRS) United States $0.218B 0.00
Geron (GERN) United States $0.214B 0.00
Aduro Biotech (ADRO) United States $0.206B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.204B 0.00
Gritstone Oncology (GRTS) United States $0.202B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.193B 1.73
XOMA (XOMA) United States $0.185B 0.00
Selecta Biosciences (SELB) United States $0.183B 0.00
ChromaDex (CDXC) United States $0.176B 0.00
OSMOTICA PHARM (OSMT) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.175B 0.00
HOOKIPA Pharma (HOOK) United States $0.173B 0.00
IVERIC Bio (ISEE) United States $0.172B 0.00
Abeona Therapeutics (ABEO) United States $0.172B 0.00
Starpharma Holdings (SPHRY) Australia $0.168B 0.00
VBI Vaccines (VBIV) United States $0.166B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Prometic Life Sciences (LMNL) Canada $0.160B 0.00
Kindred Biosciences (KIN) United States $0.160B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.158B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Windtree Therapeutics (WINT) United States $0.144B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.137B 0.00
Cerecor (CERC) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.135B 0.00
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.132B 0.00
VTv Therapeutics (VTVT) United States $0.132B 0.00
Dyadic (DYAI) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.121B 0.00
Affimed (AFMD) Germany $0.119B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.118B 0.00
Theratechnologies (THTX) Canada $0.118B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Exicure (XCUR) United States $0.115B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.110B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.102B 0.00
Strongbridge Biopharma (SBBP) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aptinyx (APTX) United States $0.095B 0.00
TELA Bio (TELA) United States $0.091B 0.00
OvaScience (MLND) United States $0.088B 0.00
Checkpoint Therapeutics (CKPT) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.086B 0.00
Five Prime Therapeutics (FPRX) United States $0.085B 0.00
Cyclerion Therapeutics (CYCN) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Eton Pharmaceuticals (ETON) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.075B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Menlo Therapeutics (MNLO) United States $0.070B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.067B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Adocia (ADOCY) France $0.066B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
SESEN BIO, INC (SESN) United States $0.062B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Orgenesis (ORGS) United States $0.061B 3.55
Synlogic (SYBX) United States $0.060B 0.00
AquaBounty Technologies (AQB) United States $0.059B 0.00
Catalyst Biosciences (CBIO) United States $0.057B 0.00
Trevena (TRVN) United States $0.056B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Acorda Therapeutics (ACOR) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.043B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Soligenix (SNGX) United States $0.038B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.036B 0.00
Lumos Pharma (LUMO) United States $0.036B 0.00
Advaxis (ADXS) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
TOCAGEN INC (TOCA) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.028B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Celsion (CLSN) United States $0.020B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.014B 0.00
AEterna Zentaris (AEZS) United States $0.013B 0.00
Aptevo Therapeutics (APVO) United States $0.013B 0.00
ATyr Pharma (LIFE) United States $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00